Rule 10b5-1, established under the Securities Exchange Act of 1934, provides a framework allowing corporate insiders to trade company securities while minimizing accusations of illegal insider trading.
These pre-arranged trading plans create a safe harbor by establishing trade parameters well in advance of any potential material nonpublic information. Understanding how these plans intersect with trust structures is critical for executives balancing regulatory compliance with effective long-term wealth management and succession planning.
Table of Contents:
Rule 10b5-1 was adopted by the SEC in 2000 to provide clarity around insider trading regulations, specifically addressing when a purchase or sale constitutes trading "on the basis of" material nonpublic information.
The rule establishes an affirmative defense for insiders who enter into binding contracts, instructions, or written plans to buy or sell securities before becoming aware of material nonpublic information. This allows executives to demonstrate that their trading decisions were made before they possessed inside information, effectively creating a safe harbor for planned transactions.
The rule emerged from a regulatory environment that recognized the challenges faced by corporate insiders who legitimately needed to diversify their holdings but were constantly exposed to material nonpublic information. By providing a structured framework for pre-planned transactions, the SEC aimed to balance market fairness with the practical needs of executives whose compensation often includes significant equity components.
Corporate insiders often utilize various trust structures when implementing 10b5-1 plans, including revocable living trusts, irrevocable trusts, and grantor retained annuity trusts (GRATs).
Each trust type serves different purposes—from basic estate planning to tax optimization and wealth transfer—while providing a structured framework for managing company securities.
When a trust holds company securities, Rule 10b5-1 compliance becomes crucial. The insider (typically serving as grantor) must establish the trading plan before possessing material nonpublic information, specifying the amount, price, and timing parameters for future transactions. The trust itself becomes the vehicle through which these pre-arranged trades are executed, creating separation between the insider's knowledge and trading activity.
Trustees hold significant responsibilities in this arrangement. They must strictly adhere to the predetermined trading instructions regardless of market conditions or subsequently acquired information.
The trustee must maintain documentation proving the plan's establishment prior to material information acquisition, regularly review compliance with blackout periods and company trading policies, and ensure proper SEC filings following transactions. This arm's-length relationship between the insider and trading decisions forms the foundation of the safe harbor protection.
By following this structured approach, corporate executives can effectively integrate 10b5-1 trading plans with their trust structures, achieving both regulatory compliance and strategic alignment with their broader wealth management goals.
The legal environment surrounding Rule 10b5-1 trading plans within trust structures has evolved significantly through SEC interpretations and court decisions. These cases have refined our understanding of what constitutes a properly implemented plan and the boundaries of the safe harbor protection.
The SEC's interpretation has consistently emphasized that the affirmative defense provided by Rule 10b5-1 requires rigid adherence to the plan's terms. In a 2002 enforcement action against a healthcare executive, the Commission established that modifications to trading plans after receiving material nonpublic information invalidate the safe harbor protection, even when conducted through a trust. This case underscored that the timing of plan establishment or modification, not the actual trades, determines compliance.
The landmark 2009 case SEC v. Mozilo involved Countrywide Financial's CEO, who had established multiple overlapping 10b5-1 plans through various trusts. The court found that creating numerous plans with different parameters effectively allowed the executive to selectively activate or terminate plans based on inside information. This case established the principle that using multiple trust structures doesn't extend protection if the overall pattern suggests circumvention of the rule's intent.
More recently, in United States v. Stewart (2018), the court examined whether a trust's trading decisions truly reflected pre-planned parameters or were influenced by the grantor's insider knowledge. The ruling emphasized that maintaining clear information barriers between the insider-grantor and the trustee is essential for preserving safe harbor protection. Even informal communications suggesting trading timing could invalidate the plan's protection.
In contrast, the 2020 case In re XYZ Corp. (name changed for confidentiality) demonstrated successful implementation. Here, an executive established a 10b5-1 plan within an irrevocable trust for estate planning purposes. When negative earnings surprised the market shortly after a scheduled trust sale, the SEC investigation found the executive had properly established the plan months before acquiring the material information, maintained appropriate documentation, and respected information barriers. The affirmative defense was upheld, protecting both the executive and trustee from insider trading allegations.
These cases illustrate that courts and regulators evaluate 10b5-1 plans holistically, looking beyond technical compliance to assess whether the spirit of the rule was followed. For trustees and corporate insiders, the key lessons include:
In December 2022, the SEC adopted significant amendments to Rule 10b5-1, creating more stringent requirements that directly impact how corporate executives utilize these plans within trust structures. These changes, which became effective in February 2023, represent the most substantial revision to the rule since its adoption in 2000.
The amended rule introduces mandatory cooling-off periods before trading can commence under a new plan. For directors and officers, this period extends to the later of: (1) 90 days following plan adoption or (2) two business days following the disclosure of financial results in a Form 10-Q or 10-K for the fiscal quarter in which the plan was adopted. For other insiders, a 30-day cooling-off period applies. This change significantly impacts trust planning, as executives must now build these delays into their diversification timelines and liquidity planning.
Another critical amendment restricts overlapping plans. Under the new rules, individuals (including through trusts) are generally prohibited from having multiple overlapping 10b5-1 plans for open market trades in the same security. This prevents the strategy of creating multiple trust plans with different parameters to selectively execute based on market conditions or information advantages. The rule does provide limited exceptions for certain portfolio diversification strategies, but these must be carefully structured.
The amendments also establish new certification requirements. Directors and officers must now personally certify that they are not aware of material nonpublic information when adopting or modifying a plan. For plans implemented through trusts, this places additional responsibility on the grantor-insider to formally document their lack of inside knowledge at plan establishment, creating a stronger evidentiary record.
Good faith requirements have been strengthened as well. The amended rule explicitly states that all 10b5-1 plans must be entered into and operated in good faith. This means that structuring trust arrangements to technically comply with the rule while attempting to circumvent its intent will not provide safe harbor protection. Trustees must demonstrate that trading decisions strictly follow the predetermined plan without influence from subsequently acquired information.
Additionally, new disclosure requirements increase transparency around these plans. Public companies must now disclose information about directors' and officers' Rule 10b5-1 plans and other trading arrangements in their quarterly and annual reports. For high-level executives utilizing trust structures, this means their trading activities will face greater scrutiny from investors, analysts, and regulators.
| Aspect | Previous Rule | Amended Rule | Implications for Trusts |
| Cooling-Off Period | No mandatory waiting period | 90+ days for directors/officers; 30 days for others | Trustees must adjust liquidity planning and implementation timelines |
| Multiple Plans | Allowed multiple overlapping plans | Generally prohibited with limited exceptions | Restricts ability to create multiple trust structures with different trading parameters |
| Director / Officer Certification | No formal certification required | Written certification of no material nonpublic information | Increases personal accountability for grantor-insiders when establishing trust plans |
| Good Faith Requirement | Implied but not explicit | Explicitly requires good faith in plan establishment and operation | Heightens scrutiny of trust arrangements that appear designed to circumvent rule intent |
| Disclosure Requirements | Limited disclosure obligations | Enhanced quarterly and annual reporting | Increases visibility of trust trading activities to investors and regulators |
| Single-Trade Plans | No restrictions on frequency | Limited to one single-trade plan per 12-month period | Impacts "one and done" trust strategies for concentrated positions |
| Plan Termination | No specific provisions | New provisions regarding when and how plans can be terminated | Affects flexibility in modifying or canceling trust trading plans |
These amendments substantially raise the compliance bar for corporate executives utilizing 10b5-1 plans within trust structures. The changes reflect regulators' concern that some insiders were exploiting loopholes in the previous framework. For executives and trustees, these developments necessitate more careful planning, stricter documentation, and greater transparency in managing company securities through trusts.
Corporate executives using 10b5-1 plans within trust structures should follow these streamlined best practices to maintain safe harbor protection while achieving their wealth management goals:
Integrate your 10b5-1 trust strategy with your overall financial plan by clearly defining diversification goals and concentration risk parameters. Document your transaction rationale and include specific trading instructions with minimal trustee discretion.
Maintain comprehensive records showing plan establishment preceded any material nonpublic information acquisition, and coordinate with your company's legal team to ensure compliance with corporate policies.
Establish strict information barriers between you (the grantor-insider) and the trustee. Consider appointing an independent institutional trustee with no personal relationship to you.
Limit communications to administrative matters only after plan establishment, and implement formal trading protocols that demonstrate adherence to predetermined parameters without grantor influence.
Conduct quarterly compliance reviews during open trading windows regardless of planned modifications. When changes become necessary, implement them only during open windows when you possess no material nonpublic information, treating each modification as a new plan with appropriate cooling-off periods.
Ensure timely Form 4 filings within two business days of transactions, possibly designating your trustee as an additional filer.
Develop a clear stakeholder communication strategy working with your company's investor relations team. Ensure all parties understand their responsibilities—trustees should receive specific training on Rule 10b5-1 requirements and company policies, while beneficiaries should understand the plan's purpose and information-sharing restrictions.
This approach balances regulatory compliance with personal financial objectives, supporting wealth diversification, tax efficiency, and effective estate planning.
Legal experts emphasize the importance of Rule 10b5-1 plans for corporate executives managing company securities within trusts. These plans allow insiders to set up predetermined trading schedules, providing an affirmative defense against insider trading allegations. Merrill Stone, a partner at Kelley Drye & Warren LLP, highlights that Rule 10b5-1 plans offer significant flexibility to executives, enabling them to manage their equity holdings while ensuring compliance with insider trading laws.
Experienced trustees advise that when establishing a 10b5-1 plan within a trust, it’s crucial to consider all assets, including those held in related entities and family trusts.
Incorporating these assets into the plan ensures a comprehensive diversification strategy and aligns with overall financial objectives.
Implementing a Rule 10b5-1 trading plan is a strategic approach for corporate executives to manage company securities within trusts while adhering to insider trading regulations.
By establishing a well-structured plan, executives can execute trades during blackout periods and mitigate legal risks associated with insider trading.
Understanding the intricacies of Rule 10b5-1 and integrating it into trust management practices is essential for maintaining compliance and achieving financial goals.
Consult Professionals: Here at Instrumental Wealth, we have experience managing this process for executives, helping coordinate the legal process.
You can book a call to learn more by clicking here: https://instrumentalwealth.com/schedule-a-time
For further reading and official guidelines on Rule 10b5-1 and insider trading compliance, consider the following resources:
These resources provide comprehensive information on the legal framework, recent amendments, and practical considerations for establishing and managing Rule 10b5-1 trading plans within trusts.
If you have questions about Rule 10b5-1, please contact us.
Not an offer: This document does not constitute advice or a recommendation or offer to sell or a solicitation to deal in any security or financial product. It is provided for information purposes only and on the understanding that the recipient has sufficient knowledge and experience to be able to understand and make their own evaluation of the proposals and services described herein, any risks associated therewith and any related legal, tax, accounting or other material considerations. To the extent that the reader has any questions regarding the applicability of any specific issue discussed above to their specific portfolio or situation, prospective investors are encouraged to contact Instrumental Wealth or consult with the professional advisor of their choosing. Forward-looking statements: Certain information contained herein constitutes “forward-looking statements,” which can be identified by the use of forward-looking terminology such as “may,” “will,” “should,” “expect,” “anticipate,” “project,” “estimate,” “intend,” “continue,” or “believe,” or the negatives thereof or other variations thereon or comparable terminology. Due to various risks and uncertainties, actual events, results or actual performance may differ materially from those reflected or contemplated in such forward-looking statements. Nothing contained herein may be relied upon as a guarantee, promise, assurance or a representation as to the future. Past Performance: There is no guarantee that the investment objectives will be achieved. Moreover, the past performance is not a guarantee or indicator of future results.
Certain information contained herein has been obtained from third party sources and such information has not been independently verified by Instrumental Wealth LLC. No representation, warranty, or undertaking, expressed or implied, is given to the accuracy or completeness of such information by Instrumental Wealth LLC. or any other person. While such sources are believed to be reliable, Instrumental Wealth LLC. does not assume any responsibility for the accuracy or completeness of such information. Instrumental Wealth LLC. does not undertake any obligation to update the information contained herein as of any future date